Translate Bio, Inc. Gains 71.98%

Thu, Sep 26, 2024 at 07:35 PM
Translate Bio, Inc. Gains 71.98%

Translate Bio, Inc. (TBIO:NASDAQ) jumped higher at $3.99, representing a gain of 72%. On Thu, Sep 26, 2024, TBIO:NASDAQ touched a New 2-Week High of $3.99. The stock got featured on our News Catalysts scanner on Wed, Sep 25, 2024 at 06:09 PM in the 'PATNERSHIP' category. From Thu, Sep 12, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Thu, Sep 19, 2024 at $5.17 with a volume of 53M+.

About Translate Bio, Inc. (TBIO:NASDAQ)

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.